✨ Your Portfolio is fetched and updated from zerodha.
Micro Chemicals
Market Cap
₹87 Cr.
P/E
49.73

Key Ratios

Market cap
Market cap
87.00 Cr
PE
PE
49.73
Prom Holding
Prom Holding
36.23 %
ROE (%)
ROE (%)
1.48
ROCE (%)
ROCE (%)
2.20
Div Yield (%)
Div Yield (%)
-
Sales
Sales
37.66 Cr
OPM (%)
OPM (%)
7.33 %
Debt to Equity
Debt to Equity
-
About
Eiko Lifesciences Limited operates as an investment company focusing on investing in shares, b… Read more
Low
42
52W Range
High
75
  • Eiko Lifesciences
  • Sunil Healthcare
  • Archit Organosys

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
Corporate Actions
Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less
FAQs on Eiko Lifesciences Ltd. Business

Eiko Lifesciences Limited operates as an investment company, dealing in various financial instruments like shares, bonds, and securities, both domestically and internationally.

Eiko Lifesciences major competitors are Archit Organosys, Daikaffil Chemicals, Sunil Healthcare, Ambani Orgochem, Mahickra Chemicals, Mysore Petro Chem, Shivam Chemicals.
Market Cap of Eiko Lifesciences is ₹87 Crs.
While the median market cap of its peers are ₹93 Crs.

Eiko Lifesciences seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation May
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material